ISIS Pharmaceuticals founder, chairman & CEO Stanley Crooke, offers insight on the status of his company's drug Kynamro, and the competition in the pharmaceutical industry.
PPG Industries chairman & CEO Charles Bunch, discusses how he works to keep his commodity chemical business consistent and a "specialty company" in a volatile and cyclical industry.
Mad Money host Jim Cramer explains why he likes B&G Foods' business model. And David Wenner, B&G Foods president & CEO, offers insight on the company's earnings.